Thyme Companies
PrivateLast Round
Series E
Sep 2, 2026
Est. Valuation
$2B
Total Funding Raised
$222M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Thyme Companies operates in Healthcare & Life Sciences and is based in Nashville, Tennessee. Its latest recorded funding round was a Series E round in September 2026.
Thyme Companies is a healthcare company that operates as a parent entity for a family of businesses focused on improving cancer care delivery, access, and affordability.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Patient Engagement, Telemedicine, Biotechnology
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Thyme Companies Comparables
Compare Thyme Companies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Roche Holding | 83% | |
| OncoHealth | 79% | |
| Reimagine Care | 73% |
For institutional investors. Book with your work email.
Thyme Companies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Sep 2, 2026 | ||||
| Series D | Sep 25, 2025 |
For institutional investors. Book with your work email.
Thyme Companies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series E, Series D |
| Town Hall Ventures | Series E, Series D |
| AlleyCorp | Series E, Series D |
| Frist Cressey Ventures | Series E, Series D |
| Texas Oncology | Series D |
| Foresite Capital | Series E, Series D |
| Morgan Health | Series D, Series E |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 2, 2026
$125M round led by Morgan Health
- Sep 25, 2025
$97M round with participation from Andreessen Horowitz and CVS Health Ventures.
For institutional investors. Book with your work email.
Thyme Companies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Thyme Companies's valuation, stock price, and market status.
Is Thyme Companies a public or private company?
Thyme Companies is a private company.
What is the current stock price of Thyme Companies?
Thyme Companies is a private company, so its shares have no public market price. Caplight tracks Thyme Companies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Thyme Companies worth (valuation)?
Thyme Companies's valuation is estimated at $2.0B based on funding round data.
Can I buy Thyme Companies stock?
Thyme Companies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Thyme Companies's last funding round?
Thyme Companies's most recent funding round was Series E on September 2, 2026.
Who are the main investors in Thyme Companies?
Key investors in Thyme Companies include Morgan Health.
Will Thyme Companies IPO soon?
No public IPO plans have been announced for Thyme Companies.
How can I track Thyme Companies secondary market activity?
Caplight tracks bids, offers, and trades in Thyme Companies's shares on secondary markets.